Clinical Trials Logo

Genital Herpes clinical trials

View clinical trials related to Genital Herpes.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04222985 Terminated - Genital Herpes Clinical Trials

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

HSV15
Start date: February 18, 2020
Phase: Phase 1
Study type: Interventional

The primary objectives of the study are: - To describe the safety profile of different investigational vaccine regimens against herpes simplex virus type 2 (HSV-2). - To evaluate the efficacy of the investigational vaccine regimens with respect to: - the frequency of herpes simplex virus (HSV) deoxyribonucleic acid (DNA) detection in the genital area (shedding rate) following a 2 dose vaccine schedule - the proportion of participants free of HSV genital recurrence at 6 months after the 2-dose vaccine schedule The secondary objectives of the study are: - To describe the impact of each of the investigational vaccine regimens in terms of total number of days with genital lesion up to 6 months after vaccination 2 and number of recurrences 60 days after the second vaccination compared with the placebo group - To describe the efficacy of each of the investigational vaccine regimens with respect to the frequency of HSV DNA detection in the genital area (shedding rate) 60 days following the first vaccination visit plus 60 days following the second vaccination visit compared with the placebo group - To describe the efficacy of each of the investigational vaccine regimens with respect to the frequency of HSV DNA detection in the genital area (shedding rate) 60 days following the first vaccination visit compared with the placebo group

NCT ID: NCT03146403 Terminated - Genital Herpes Clinical Trials

Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

Start date: May 24, 2017
Phase: Phase 2
Study type: Interventional

The main purpose of this clinical study is to see if a maintenance dose of GEN-003 reduces the number of days that subjects have a genital herpes recurrence. The second purpose of the study is to evaluate the safety and tolerability of a maintenance dose of GEN-003.

NCT ID: NCT01765114 Terminated - Genital Herpes Clinical Trials

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

Start date: February 2013
Phase: Phase 2
Study type: Interventional

The aim of this study is therefore to investigate the efficacy of the PEG-formulation to reduce the frequency and duration of genital herpes recurrences, to assess its safety and tolerability and to investigate its effect on shedding.

NCT ID: NCT01658826 Terminated - Genital Herpes Clinical Trials

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The aim of the study is to evaluate the safety and efficacy of "AIC316 (pritelivir)" 100 mg once daily compared to valacyclovir 500 mg once daily for the prevention of HSV-2 genital shedding.

NCT ID: NCT00495716 Terminated - Genital Herpes Clinical Trials

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine what effect suppressive therapy has on sexual behavior and quality of life among persons with genital herpes (HSV) who have multiple sex partners. Study terminated; investigator relocated and study funding ended. Results were never analyzed because data were not collected.